Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 901,890 shares at $39.26 ($34.5M) on 2024-07-09, disclosed to the SEC on 2024-07-09.
Scheduled sale ($34.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.57 | 24,449 | $870K | 2.5% |
| 2 | $35.57 | 24,449 | $870K | 2.5% |
| 3 | $35.57 | 5,133 | $183K | 0.5% |
| 4 | $35.57 | 5,133 | $183K | 0.5% |
| 5 | $36.40 | 28,718 | $1.0M | 3.0% |
| 6 | $36.40 | 6,030 |
| $219K |
| 0.6% |
| 7 | $36.40 | 28,718 | $1.0M | 3.0% |
| 8 | $37.41 | 8,769 | $328K | 1.0% |
| 9 | $37.41 | 8,769 | $328K | 1.0% |
| 10 | $37.41 | 41,763 | $1.6M | 4.5% |
| 11 | $37.41 | 41,763 | $1.6M | 4.5% |
| 12 | $38.48 | 38,606 | $1.5M | 4.3% |
| 13 | $38.48 | 38,606 | $1.5M | 4.3% |
| 14 | $38.48 | 183,868 | $7.1M | 20.5% |
| 15 | $38.48 | 183,868 | $7.1M | 20.5% |
| 16 | $39.26 | 20,238 | $795K | 2.3% |
| 17 | $39.26 | 96,386 | $3.8M | 11.0% |
| 18 | $39.26 | 96,386 | $3.8M | 11.0% |
| 19 | $39.26 | 20,238 | $795K | 2.3% |
| Total | $38.22 avg | 901,890 | $34.5M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $56.5M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |